Board and Staff

This section provides information in relation to the Medicines Australia Board, Secretariat and organisation structure.

Board | Secretariat | Organisational Structure

Medicines Australia Board 2008 - 2010

Directors

Mr Will Delaat -  Independent Chairman
Mr Klaus Abel Managing Director Lundbeck Australia Pty Ltd
Dr Graeme Blackman Chairman Institute of Drug Technology Australia Ltd
Mr Bruce Goodwin Managing Director Janssen-Cilag Pty Ltd
Mr Frederic Guerard Managing Director Novartis Pharmaceuticals Australia Pty Ltd
Mr John Latham Regional Director (Australia &New Zealand) Pfizer Australia
Ms Jane Orr Managing Director Merck Sharp & Dohme Australia Pty Ltd
Mr Ian Thompson Managing Director Amgen Australia Pty Ltd
Mr José Antonio T Vieira Managing Director AstraZeneca Pty Ltd
Ms Deborah Waterhouse Vice President and General Manager Australasia GlaxoSmithKline Australia

Secretariat
Position	Person
Chief Executive	Brendan Shaw
Executive Assistant to the Chief Executive	Louise Collett
Director, Health Policy and Research	Andrew Bruce
Executive Director, Public Affairs	Donna Edman
Director, Innovation and Industry Policy	Deborah Monk
Director, Corporate Services	Katie Whitehead
Reimbursement Strategies Manager	Jim Crompton
Policy Manager	Michael Fitzsimons
Regulatory Affairs Manager	Elizabeth De Somer
Research Manager	Amish Chaturvedi
Media Communications Manager	Jamie Nicholson
Stakeholder Relations Manager	Diana Terry
Code of Conduct Manager	Sophie Hibburd
Finance Manager	Di Phillips
IT Manager	David Newman
Policy and Research Officer	Sam Shirley
Policy Coordination Officer	Vacant
Public Affairs Officer	Vacant
Personal Assistant to Innovation & Industry Policy & Public Affairs Directors	Juanita Wenham
Senior Innovation and Industry Policy Officer	Omar Khan
Code Administration Officer	Romina Bognolo
Executive Officer	Jannelle Andre Morgan
Office Manager	Joanne Toogood
Finance Assistant	Prya Sonah